ArticleBMJ open2026

Safety and early efficacy of iPSC-derived motor neuron progenitor cells in subacute spinal cord injury: protocol for a phase I, multicentre, open-label, single-arm trial.

Mao Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.